MedTrace Logo

DEFINing the PrEvalence and Characteristics of Coronary Artery Disease Among Patients With TYPE 2 Myocardial Infarction Using CT-FFR

NCT04864119 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2024-03-13

No results posted yet for this study

Summary

The primary objectives of this study include:

* determine the prevalence of coronary artery disease among patients with type 2 myocardial infarction
* determine the prevalence of hemodynamically significant stenosis among patients with type 2 myocardial infarction

The investigators hypothesize that patients with type 2 myocardial infarction will have a high burden of coronary artery plaque and a high prevalence of obstructive coronary artery disease with hemodynamic significance.

Conditions

  • Type 2 Myocardial Infarction

Sponsors & Collaborators

  • HeartFlow, Inc.

    collaborator INDUSTRY

  • Massachusetts General Hospital

    lead OTHER

Principal Investigators

  • James L Januzzi, MD · Massachusetts General Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-11
Primary Completion
2023-02-03
Completion
2024-03-11

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04864119 on ClinicalTrials.gov